Hiring in life sciences? Share your open positions with our professional community. Read more Close

Your cookie settings

This site uses cookies. Some cookies are essential to make the site work and others help us to improve our services. Read more about cookies in our Privacy policy.

Choose your cookie preferences:

Advertisement

Effect of upadacitinib and ABBV-599 on biomarkers in SLE: results from the phase 2 SLEek study.

Created on 30 Oct 2026

Authors

Marie-Claude Gaudreau, Michelle Catalina, Thierry Sornasse, Archana Iyer, Ioan Filip, Shalina Contrepois, James Fann, Joan T Merrill

Published in

Lupus science & medicine. Volume 13. Issue 2. Oct 29, 2026. Epub Oct 29, 2026.

PMID:
42957324
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Sign in to post a review. Add review
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Do you recommend this? Please sign in. Yes No

Recommended

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement